Investment opportunity! Contact us for information on investment

Ora Pharm Introduces New Service Offering to Enhance New Zealand’s Medicinal Cannabis Industry

by | Jun 20, 2024

Ora Pharm is proud to announce the launch of its new plant processing and export services for other medicinal cannabis cultivators across the country. This strategic move is set to lower barriers to entry and improve profitability for medicinal cannabis growers by reducing costs associated with plant processing, streamlining the export process, ensuring rigorous quality control, and improving overall efficiency.

 

Currently, around one-third of New Zealand’s licensed cannabis cultivators have chosen to collaborate with Ora Pharm, leveraging these new services to enhance their operations. By accessing Ora Pharm’s resources, these cultivators can significantly lower production costs and optimise their supply chain. Centralising these crucial operations with Ora Pharm ensures that all products meet the highest standards of quality and compliance, facilitating smoother export processes and a more consistent flow of New Zealand grown cannabis exports to international markets.

 

“Our mission at Ora Pharm is to bolster the growth and sustainability of New Zealand’s medicinal cannabis industry,” says Zoe Reece, CEO of Ora Pharm. “By providing these specialised services, we allow cultivators to focus on their core competency — growing premium medicinal cannabis — while we handle the processing and export logistics. This cooperative approach not only cuts costs but also enhances the overall quality and reliability of New Zealand’s medicinal cannabis in the global market.”

 

In addition to these new services, Ora Pharm is thrilled to announce that Breathe Life Sciences Pty Ltd, a division of Bioxyne Ltd (BXN:ASX), a global leader in medicinal cannabis, has selected Ora Pharm as the only supplier from New Zealand on its AI generated Cannabis trading platform CanXChange. This development is based on Ora Pharm’s capability to represent products from multiple cultivators, which ensures that the best of New Zealand’s medicinal cannabis products are represented on the platform. This exclusive supply agreement opens significant opportunities for New Zealand products to penetrate the Australian market.

 

CanXChange is designed to revolutionise the trading of medicinal cannabis in Australia, offering a centralised platform for buyers and sellers. As the exclusive New Zealand supplier, Ora Pharm will ensure that CanXChange customers have access to the highest quality medicinal cannabis products that New Zealand has to offer, based on their stringent quality standards and therapeutic efficacy.

 

“We are excited about our partnership with CanXChange and the opportunity to bring New Zealand’s superior medicinal cannabis products to the Australian market,” added Zoe Reece. “This agreement is a testament to the quality of our products and our dedication to excellence in every facet of our operations.”

 

Sally King, Executive Director of the New Zealand Medicinal Cannabis Council (NZMCC), highlighted the industry-wide benefits of Ora Pharm’s new services and partnerships: “New Zealand’s approach to this sunrise sector is to work collaboratively, supporting all participants – craft cultivators to vertically integrated suppliers – to expand NZ’s reputation for sustainable, ethical, highest quality medicinal cannabis genetics, ingredients and medicines. Ora Pharm’s new export service is another significant step to growing New Zealand’s share of premium, patient-focussed medicinal cannabis solutions for the world. An important and very welcome development”

 

About Ora Pharm

Ora Pharm is a New Zealand-based company specialising in the cultivation, processing, and distribution of high-quality medicinal cannabis. Committed to sustainability, innovation, and stringent quality control, Ora Pharm aims to support the health and well-being of patients worldwide.

 

About CanXChange

CanXChange is an innovative marketplace dedicated to the trading of medicinal cannabis products in Australia. By offering a trusted platform for transactions, CanXChange aims to streamline the process and ensure the availability of high-quality medicinal cannabis to meet patient needs.

 

For media inquiries, please contact:

Ora Pharm

Phone: +64 9 929 8761

Email: info@orapharm.co.nz

Website: www.orapharm.co.nz

Recent Posts

Boosting Business with New Medicinal Cannabis Regulations

Boosting Business with New Medicinal Cannabis Regulations

These regulatory changes are a game-changer for Ora Pharm. By providing greater flexibility in product development and quality control, we can innovate more freely and respond more effectively to market demands. The ability to export and import cannabis materials for research and testing significantly enhances our capacity to collaborate internationally and improve our product offerings.

read more
Ora Pharm leads New Zealand Medicinal Cannabis exports to Australia

Ora Pharm leads New Zealand Medicinal Cannabis exports to Australia

Waikato-based Ora Pharm has successfully completed its first export order of just under 100kg high quality medicinal cannabis dried flower product to its Australian distribution partner Canngea. It is one of the first New Zealand companies to break into this market. Further orders for ongoing supply have been secured.

read more
Boosting Business with New Medicinal Cannabis Regulations

Boosting Business with New Medicinal Cannabis Regulations

These regulatory changes are a game-changer for Ora Pharm. By providing greater flexibility in product development and quality control, we can innovate more freely and respond more effectively to market demands. The ability to export and import cannabis materials for research and testing significantly enhances our capacity to collaborate internationally and improve our product offerings.

read more
Ora Pharm leads New Zealand Medicinal Cannabis exports to Australia

Ora Pharm leads New Zealand Medicinal Cannabis exports to Australia

Waikato-based Ora Pharm has successfully completed its first export order of just under 100kg high quality medicinal cannabis dried flower product to its Australian distribution partner Canngea. It is one of the first New Zealand companies to break into this market. Further orders for ongoing supply have been secured.

read more

Stay Informed

Get the latest medicinal cannabis news, research, and company updates.

[/db_pb_signup]